Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
TargeGen, Inc. is a privately held vascular biology focused biopharmaceutical company based in San Diego, CA. TargeGen is developing novel small molecule therapeutics to treat diseases that involve edema, angiogenesis and inflammation as key elements of disease pathology by selectively targeting certain kinases associated with the formation and repair of blood vessels, vascular permeability (edema) and inflammation. TargeGen, which initiated operations in 2002, has raised more than $70M from top tier venture capital ( www.targegen.com )
TargeGen , Inc.
9393 Towne Centre Drive Suite 120
San Diego, California 92121
USA
Tel: (858) 678-0760
Fax: (858) 678-0762